Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9HP9Z | — |
Expired dose administered; Infanrix administered instead of Boostrix to adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 78-year-old female patient who received DTPa (Infanrix) (batch number 9HP9Z, expiry date 21-APR-2024) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. Previously administered products included Dtpa (first dose given on July 22nd 2013, unknown brand name, manufactured by Sanofi, lot number C4432AB) and Adacel (second dose was Adacel given on January 20th 2015). On 11-JUN-2025, the patient received Infanrix. On an unknown date, the patient received Boostrix. On 11-JUN-2025, an unknown time after receiving Infanrix and not applicable after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered) and wrong vaccine administered (Verbatim: Infanrix administered instead of Boostrix to adult patient). The outcome of the expired vaccine used and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-JUN-2025 Practice Manager explained they accidentally administered Infanrix instead of Boostrix to an adult patient on June 11th 2025 which led to wrong vaccine administered. During the call it was also discovered that Infanrix was already expired, it expired on April 21st 2024 which led to expired vaccine used. There were 2 prior Diphtheria, Tetanus and Pertussis vaccines administered to this patient, first dose given on July 22nd 2013 (unknown brand name, manufactured by Sanofi, lot number C4432AB), and second dose was Adacel given on January 20th 2015.